Prenatal treatment path for angelman syndrome and other neurodevelopmental disorders.
Mark J Zylka
PMID 31490639WHAT IT FOUND
This paper proposes a future path for treating Angelman syndrome before birth using gene therapy.
It is a theoretical roadmap based on animal models and genetic mechanisms. It contains no clinical trial results or patient outcomes to guide current therapy.
What this paper is
This is a theoretical review and roadmap for future prenatal gene therapy research in Angelman syndrome. It discusses mouse models, genetic mechanisms, and proposed clinical trials, but reports no original patient data, no completed clinical outcomes, and no results from a study of human participants. There is nothing here to change your current practice on.
The easy way to misread this
Do not interpret this as evidence that prenatal gene therapy is currently available or proven effective for Angelman syndrome. This is a proposal for future research and does not describe any treatments that have been tested in humans.